Information Letter on Xofigo® (radium 223 dichloride): Temporary shortage of the medicinal product
2014.11.05
Active substance: radium-223-dichlorid
The company Bayer Vital GmbH is circulating information on a worldwide temporary shortage of the medicinal product Xofigo® as recently produced batches did not pass routine quality checks prior to release.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN